GRIM-19 function in cancer development

Mitochondrion

Volumn 11, Issue 5, 2011, Pages 693-699

  Moreira, Severina ^a   Correia, Marcelo ^a   Soares, Paula ^a,b   Máximo, Valdemar ^a,b  

^a UNIVERSITY OF PORTO   (Portugal)

^b University of Porto   (Portugal)

Author keywords

GRIM 19; Mitochondrial protein; STAT3; Tumorigenesis

Indexed keywords

CYCLIN DEPENDENT KINASE INHIBITOR 2A; OLFACTOMEDIN 4 PROTEIN; PROTEIN GW112; PROTEIN P53; STAT3 PROTEIN; TUMOR SUPPRESSOR PROTEIN; UNCLASSIFIED DRUG;

CARCINOGENESIS; CELL TRANSFORMATION; DOWN REGULATION; GENE FUNCTION; GENE MUTATION; GRIM 19 GENE; HUMAN; NONHUMAN; PRIORITY JOURNAL; PROTEIN EXPRESSION; PROTEIN FUNCTION; PROTEIN INTERACTION; PROTEIN TARGETING; REVIEW; TUMOR SUPPRESSOR GENE;

ANIMALS; APOPTOSIS REGULATORY PROTEINS; CELL TRANSFORMATION, NEOPLASTIC; CYCLIN-DEPENDENT KINASE INHIBITOR P16; ELECTRON TRANSPORT; GENE EXPRESSION; GRANULOCYTE COLONY-STIMULATING FACTOR; HUMANS; MITOCHONDRIAL PROTEINS; NADH, NADPH OXIDOREDUCTASES; NEOPLASMS; STAT3 TRANSCRIPTION FACTOR;

EID: 79961208847     PISSN: 15677249     EISSN: 18728278     Source Type: Journal    
DOI: 10.1016/j.mito.2011.05.011     Document Type: Review

References (63)

1. Alchanati I., Nallar S.C., Sun P., Gao L., Hu J., Stein A., Yakirevich E., Konforty D., Alroy I., Zhao X., Reddy S.P., Resnick M.B., Kalvakolanu D.V. A proteomic analysis reveals the loss of expression of the cell death regulatory gene GRIM-19 in human renal cell carcinomas. Oncogene 2006, 25:7138-7147.
2. Altucci L., Gronemeyer H. The promise of retinoids to fight against cancer. Nat. Rev. Cancer 2001, 1:181-193.
3. Angell J.E., Lindner D.J., Shapiro P.S., Hofmann E.R., Kalvakolanu D.V. Identification of GRIM-19, a novel cell death-regulatory gene induced by the interferon-beta and retinoic acid combination, using a genetic approach. J. Biol. Chem. 2000, 275:33416-33426.
4. Attardi G., Yoneda M., Chomyn A. Complementation and segregation behavior of disease-causing mitochondrial DNA mutations in cellular model systems. Biochim. Biophys. Acta 1995, 1271:241-248.
5. Barnich N., Hisamatsu T., Aguirre J.E., Xavier R., Reinecker H.C., Podolsky D.K. GRIM-19 interacts with nucleotide oligomerization domain 2 and serves as downstream effector of anti-bacterial function in intestinal epithelial cells. J. Biol. Chem. 2005, 280:19021-19026.
6. Baysal B.E., Ferrell R.E., Willett-Brozick J.E., Lawrence E.C., Myssiorek D., Bosch A., van der Mey A., Taschner P.E., Rubinstein W.S., Myers E.N., Richard C.W., Cornelisse C.J., Devilee P., Devlin B. Mutations in SDHD, a mitochondrial complex II gene, in hereditary paraganglioma. Science 2000, 287:848-851.
7. Bromberg J.F., Wrzeszczynska M.H., Devgan G., Zhao Y., Pestell R.G., Albanese C., Darnell J.E. Stat3 as an oncogene. Cell 1999, 98:295-303.
8. Buettner R., Mora L.B., Jove R. Activated STAT signaling in human tumors provides novel molecular targets for therapeutic intervention. Clin. Cancer Res. 2002, 8:945-954.
9. Canzian F., Amati P., Harach H.R., Kraimps J.L., Lesueur F., Barbier J., Levillain P., Romeo G., Bonneau D. A gene predisposing to familial thyroid tumors with cell oxyphilia maps to chromosome 19p13.2. Am. J. Hum. Genet. 1998, 63:1743-1748.
10. Chidambaram N.V., Angell J.E., Ling W., Hofmann E.R., Kalvakolanu D.V. Chromosomal localization of human GRIM-19, a novel IFN-beta and retinoic acid-activated regulator of cell death. J. Interferon Cytokine Res. 2000, 20:661-665.
11. Chin K.L., Aerbajinai W., Zhu J., Drew L., Chen L., Liu W., Rodgers G.P. The regulation of OLFM4 expression in myeloid precursor cells relies on NF-kappaB transcription factor. Br. J. Haematol. 2008, 143:421-432.
12. DeBerardinis R.J. Is cancer a disease of abnormal cellular metabolism? New angles on an old idea. Genet. Med. 2008, 10:767-777.
13. Dyson N. The regulation of E2F by pRB-family proteins. Genes Dev. 1998, 12:2245-2262.
14. Fearnley I.M., Carroll J., Shannon R.J., Runswick M.J., Walker J.E., Hirst J. GRIM-19, a cell death regulatory gene product, is a subunit of bovine mitochondrial NADH: ubiquinone oxidoreductase (complex I). J. Biol. Chem. 2001, 276:38345-38348.
15. Gatenby R.A., Gillies R.J. Why do cancers have high aerobic glycolysis?. Nat. Rev. Cancer 2004, 4:891-899.
16. Gong L.B., Luo X.L., Liu S.Y., Tao D.D., Gong J.P., Hu J.B. Correlations of GRIM-19 and its target gene product STAT3 to malignancy of human colorectal carcinoma. Ai Zheng 2007, 26:683-687.
17. Gough D.J., Corlett A., Schlessinger K., Wegrzyn J., Larner A.C., Levy D.E. Mitochondrial STAT3 supports Ras-dependent oncogenic transformation. Science 2009, 324:1713-1716.
18. Gresser I., Belardelli F. Endogenous type I interferons as a defense against tumors. Cytokine Growth Factor Rev. 2002, 13:111-118.
19. Guerra S., Lopez-Fernandez L.A., Pascual-Montano A., Munoz M., Harshman K., Esteban M. Cellular gene expression survey of vaccinia virus infection of human HeLa cells. J. Virol. 2003, 77:6493-6506.
20. Hooper A.T., Akiri G., Jin D., Shmelkov S.V., Chuang E., Shin S.J., Wu Y., Hicklin D.J., Rafii S., Vahdat L.T. VEGF receptor expression on reactive breast cancer stroma: paving the way for tumor invasion. ASCO Meeting Abstracts 2005, 23:9642.
21. Hsu P.P., Sabatini D.M. Cancer cell metabolism: Warburg and beyond. Cell 2008, 134:703-707.
22. Hu J., Angell J.E., Zhang J., Ma X., Seo T., Raha A., Hayashi J., Choe J., Kalvakolanu D.V. Characterization of monoclonal antibodies against GRIM-19, a novel IFN-beta and retinoic acid-activated regulator of cell death. J. Interferon Cytokine Res. 2002, 22:1017-1026.
23. Huang G., Lu H., Hao A., Ng D.C.H., Ponniah S., Guo K., Lufei C., Zeng Q., Cao X. GRIM-19, a cell death regulatory protein, is essential for assembly and function of mitochondrial complex I. Mol. Cell. Biol. 2004, 24:8447-8456.
24. Huang Y., Yang M., Yang H., Zeng Z. Upregulation of the GRIM-19 gene suppresses invasion and metastasis of human gastric cancer SGC-7901 cell line. Exp. Cell Res. 2010, 316:2061-2070.
25. Ikeda H., Old L.J., Schreiber R.D. The roles of IFN gamma in protection against tumor development and cancer immunoediting. Cytokine Growth Factor Rev. 2002, 13:95-109.
26. Jin H., Pan Y., He L., Zhai H., Li X., Zhao L., Sun L., Liu J., Hong L., Song J., Xie H., Gao J., Han S., Li Y., Fan D. p75 neurotrophin receptor inhibits invasion and metastasis of gastric cancer. Mol. Cancer Res. 2007, 5:423-433. 10.1158/1541-7786.MCR-06-0407.
27. Kalakonda S., Nallar S.C., Gong P., Lindner D.J., Goldblum S.E., Reddy S.P., Kalvakolanu D.V. Tumor suppressive protein gene associated with retinoid-interferon-induced mortality (GRIM)-19 inhibits src-induced oncogenic transformation at multiple levels. Am. J. Pathol. 2007, 171:1352-1368.
28. Kalakonda S., Nallar S.C., Lindner D.J., Hu J., Reddy S.P., Kalvakolanu D.V. Tumor-suppressive activity of the cell death activator GRIM-19 on a constitutively active signal transducer and activator of transcription 3. Cancer Res. 2007, 67:6212-6220.
29. Kalvakolanu D.V., Nallar S.C., Kalakonda S. Cytokine-induced tumor suppressors: a GRIM story. Cytokine 2010, 52:128-142.
30. Katoh R., Harach H.R., Williams E.D. Solitary, multiple, and familial oxyphil tumours of the thyroid gland. J. Pathol. 1998, 186:292-299.
31. Kobayashi D., Koshida S., Moriai R., Tsuji N., Watanabe N. Olfactomedin 4 promotes S-phase transition in proliferation of pancreatic cancer cells. Cancer Sci. 2007, 98:334-340.
32. Koshida S., Kobayashi D., Moriai R., Tsuji N., Watanabe N. Specific overexpression of OLFM4(GW112/HGC-1) mRNA in colon, breast and lung cancer tissues detected using quantitative analysis. Cancer Sci. 2007, 98:315-320.
33. Lima J., Feijao T., Ferreira da Silva A., Pereira-Castro I., Fernandez-Ballester G., Maximo V., Herrero A., Serrano L., Sobrinho-Simoes M., Garcia-Rostan G. High frequency of germline succinate dehydrogenase mutations in sporadic cervical paragangliomas in northern Spain: mitochondrial succinate dehydrogenase structure-function relationships and clinical-pathological correlations. J. Clin. Endocrinol. Metab. 2007, 92:4853-4864.
34. Lufei C., Ma J., Huang G., Zhang T., Novotny-Diermayr V., Ong C.T., Cao X. GRIM-19, a death-regulatory gene product, suppresses Stat3 activity via functional interaction. EMBO J. 2003, 22:1325-1335.
35. Martin G.S. The hunting of the Src. Nat. Rev. Mol. Cell Biol. 2001, 2:467-475.
36. Maximo V., Soares P., Lima J., Cameselle-Teijeiro J., Sobrinho-Simoes M. Mitochondrial DNA somatic mutations (point mutations and large deletions) and mitochondrial DNA variants in human thyroid pathology: a study with emphasis on Hurthle cell tumors. Am. J. Pathol. 2002, 160:1857-1865.
37. Maximo V., Botelho T., Capela J., Soares P., Lima J., Taveira A., Amaro T., Barbosa A.P., Preto A., Harach H.R., Williams D., Sobrinho-Simoes M. Somatic and germline mutation in GRIM-19, a dual function gene involved in mitochondrial metabolism and cell death, is linked to mitochondrion-rich (Hurthle cell) tumours of the thyroid. Br. J. Cancer 2005, 92:1892-1898.
38. Maximo V., Lima J., Soares P., Silva A., Bento I., Sobrinho-Simoes M. GRIM-19 in health and disease. Adv. Anat. Pathol. 2008, 15:46-53.
39. Maximo V., Lima J., Soares P., Sobrinho-Simoes M. Mitochondria and cancer. Virchows Arch. 2009, 454:481-495.
40. Murray J., Zhang B., Taylor S.W., Oglesbee D., Fahy E., Marusich M.F., Ghosh S.S., Capaldi R.A. The subunit composition of the human NADH dehydrogenase obtained by rapid one-step immunopurification. J. Biol. Chem. 2003, 278:13619-13622.
41. Nallar S.C., Kalakonda S., Sun P., Ohmori Y., Hiroi M., Mori K., Lindner D.J., Kalvakolanu D.V. Identification of a structural motif in the tumor-suppressive protein GRIM-19 required for its antitumor activity. Am. J. Pathol. 2010, 177:896-907.
42. Okamoto T., Inozume T., Mitsui H., Kanzaki M., Harada K., Shibagaki N., Shimada S. Overexpression of GRIM-19 in cancer cells suppresses STAT3-mediated signal transduction and cancer growth. Mol. Cancer Ther. 2010, 9:2333-2343.
43. Pahl H.L. Activators and target genes of Rel/NF-kappaB transcription factors. Oncogene 1999, 18:6853-6866.
44. Prazeres H., Rodrigues F., Soares P., Naidenov P., Figueiredo P., Campos B., Lacerda M., Martins T. Loss of heterozygosity at 19p13.2 and 2q21 in tumours from familial clusters of non-medullary thyroid carcinoma. Fam. Cancer 2008, 7:141-149.
45. Reeves M.B., Davies A.A., McSharry B.P., Wilkinson G.W., Sinclair J.H. Complex I binding by a virally encoded RNA regulates mitochondria-induced cell death. Science 2007, 316:1345-1348.
46. Ruas M., Peters G. The p16INK4a/CDKN2A tumor suppressor and its relatives. Biochim. Biophys. Acta 1998, 1378:F115-F177.
47. Seo T., Lee D., Shim Y.S., Angell J.E., Chidambaram N.V., Kalvakolanu D.V., Choe J. Viral interferon regulatory factor 1 of Kaposi's sarcoma-associated herpesvirus interacts with a cell death regulator, GRIM19, and inhibits interferon/retinoic acid-induced cell death. J. Virol. 2002, 76:8797-8807.
48. Sherr C.J., Roberts J.M. Inhibitors of mammalian G1 cyclin-dependent kinases. Genes Dev. 1995, 9:1149-1163.
49. Stankov K., Pastore A., Toschi L., McKay J., Lesueur F., Kraimps J., Bonneau D., Gibelin H., Levillain P., Volante M., Papotti M., Romeo G. Allelic loss on chromosomes 2q21 and 19p 13.2 in oxyphilic thyroid tumors. Int. J. Cancer 2004, 111:463-467.
50. Sun P., Nallar S.C., Kalakonda S., Lindner D.J., Martin S.S., Kalvakolanu D.V. GRIM-19 inhibits v-Src-induced cell motility by interfering with cytoskeletal restructuring. Oncogene 2009, 28:1339-1347.
51. Sun P., Nallar S.C., Raha A., Kalakonda S., Velalar C.N., Reddy S.P., Kalvakolanu D.V. GRIM-19 and p16INK4a synergistically regulate cell cycle progression and E2F1-responsive gene expression. J. Biol. Chem. 2010, 285:27545-27552.
52. Tomlinson I.P., Alam N.A., Rowan A.J., Barclay E., Jaeger E.E., Kelsell D., Leigh I., Gorman P., Lamlum H., Rahman S., Roylance R.R., Olpin S., Bevan S., Barker K., Hearle N., Houlston R.S., Kiuru M., Lehtonen R., Karhu A., Vilkki S., Laiho P., Eklund C., Vierimaa O., Aittomaki K., Hietala M., Sistonen P., Paetau A., Salovaara R., Herva R., Launonen V., Aaltonen L.A. Germline mutations in FH predispose to dominantly inherited uterine fibroids, skin leiomyomata and papillary renal cell cancer. Nat. Genet. 2002, 30:406-410.
53. Tripathy M.K., Ahmed Z., Ladha J.S., Mitra D. The cell death regulator GRIM-19 is involved in HIV-1 induced T-cell apoptosis. Apoptosis 2010, 15:1453-1460.
54. Vander Heiden M.G., Cantley L.C., Thompson C.B. Understanding the Warburg effect: the metabolic requirements of cell proliferation. Science 2009, 324:1029-1033.
55. Warburg O. On the origin of cancer cells. Science 1956, 123:309-314.
56. Wegrzyn J., Potla R., Chwae Y.-J., Sepuri N.B.V., Zhang Q., Koeck T., Derecka M., Szczepanek K., Szelag M., Gornicka A., Moh A., Moghaddas S., Chen Q., Bobbili S., Cichy J., Dulak J., Baker D.P., Wolfman A., Stuehr D., Hassan M.O., Fu X.-Y., Avadhani N., Drake J.I., Fawcett P., Lesnefsky E.J., Larner A.C. Function of mitochondrial Stat3 in cellular respiration. Science 2009, 323:793-797.
57. Yang J., Chatterjee-Kishore M., Staugaitis S.M., Nguyen H., Schlessinger K., Levy D.E., Stark G.R. Novel roles of unphosphorylated STAT3 in oncogenesis and transcriptional regulation. Cancer Res. 2005, 65:939-947.
58. Yeo W.M., Isegawa Y., Chow V.T. The U95 protein of human herpesvirus 6B interacts with human GRIM-19: silencing of U95 expression reduces viral load and abrogates loss of mitochondrial membrane potential. J. Virol. 2008, 82:1011-1020.
59. Zhang J., Yang J., Roy S.K., Tininini S., Hu J., Bromberg J.F., Poli V., Stark G.R., Kalvakolanu D.V. The cell death regulator GRIM-19 is an inhibitor of signal transducer and activator of transcription 3. PNAS 2003, 100:9342-9347.
60. Zhang X., Huang Q., Yang Z., Li Y., Li C.-Y. GW112, a novel antiapoptotic protein that promotes tumor growth. Cancer Res. 2004, 64:2474-2481.
61. Zhang L., Gao L., Li Y., Lin G., Shao Y., Ji K., Yu H., Hu J., Kalvakolanu D.V., Kopecko D.J., Zhao X., Xu D.-Q. Effects of plasmid-based Stat3-specific short hairpin RNA and GRIM-19 on PC-3M tumor cell growth. Clin. Cancer Res. 2008, 14:559-568.
62. Zhou Q., Amar S. Identification of proteins differentially expressed in human monocytes exposed to Porphyromonas gingivalis and its purified components by high-throughput immunoblotting. Infect. Immun. 2006, 74:1204-1214.
63. Zhou Y., Li M., Wei Y., Feng D., Peng C., Weng H., Ma Y., Bao L., Nallar S., Kalakonda S., Xiao W., Kalvakolanu D.V., Ling B. Down-regulation of GRIM-19 expression is associated with hyperactivation of STAT3-induced gene expression and tumor growth in human cervical cancers. J. Interferon Cytokine Res. 2009, 29:695-703.